Harry Relouw

Harry Relouw is an experienced professional who has held various finance and management positions in different companies within the pharmaceutical and technology industries. Harry is currently serving as the General Manager & CFO at Basic Pharma Group, a pharmaceutical company focused on niche products. Prior to this, Harry was the Chief Financial Officer at Matisse Pharmaceuticals, where Harry played a key role in in-licensing a patent for a novel treatment for sepsis. Harry has also worked in finance and control roles at companies such as Prosensa Therapeutics B.V., Ericsson, AkzoNobel, DSM, and Rhein Biotech NV. Harry holds a post graduate degree in Finance from Open Universiteit.